Maia Biotechnology, Inc. MAIA
Institutional shares held
2.35 Million
0
calls
0
puts
Total value of holdings
$2.44M
$0
calls
$0
puts
Market Cap
$11.4M
10,935,900
Shares Out.
Institutional ownership
21.47%
# of Institutions
21
We take great care to ensure that the data presented and summarized in this overview for MAIA Biotechnology, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding MAIA
View all-
Vanguard Group Inc Valley Forge, PA1.1MShares$1.15 Million0.0% of portfolio
-
Centric Wealth Management575KShares$597,8930.21% of portfolio
-
Geode Capital Management, LLC Boston, MA271KShares$281,8980.0% of portfolio
-
Marshall Wace, LLP London, X0110KShares$114,8850.0% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$81,6610.0% of portfolio
-
State Street Corp Boston, MA75.6KShares$78,5720.0% of portfolio
-
Northern Trust Corp Chicago, IL39KShares$40,5930.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX36KShares$37,4400.0% of portfolio
-
Centerpoint Advisory Group Overland Park, KS15.7KShares$16,3590.02% of portfolio
-
Wealth Enhancement Advisory Services, LLC14.8KShares$15,3920.0% of portfolio
Latest Institutional Activity in MAIA
Top Purchases
Top Sells
About MAIA
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.
Insider Transactions at MAIA
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2025
|
Ngar Yee Louie Director |
BUY
Open market or private purchase
|
Direct |
81,699
+6.14%
|
$81,699
$1.22 P/Share
|
|
Dec 22
2025
|
Steven M Chaouki Director |
BUY
Open market or private purchase
|
Direct |
40,849
+21.2%
|
$40,849
$1.22 P/Share
|
|
Dec 22
2025
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
57,189
+3.87%
|
$57,189
$1.22 P/Share
|
|
Dec 05
2025
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
13,740
+50.0%
|
$13,740
$1.2 P/Share
|
|
Nov 28
2025
|
Vlad Vitoc Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
50,000
+5.37%
|
$50,000
$1.14 P/Share
|
|
Nov 28
2025
|
Cristian Luput Director |
BUY
Open market or private purchase
|
Direct |
18,145
+3.98%
|
$18,145
$1.11 P/Share
|
|
Nov 26
2025
|
Vlad Vitoc Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
22,000
+2.51%
|
$22,000
$1.05 P/Share
|
|
Nov 26
2025
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
15,000
+1.09%
|
$15,000
$1.04 P/Share
|
|
Nov 26
2025
|
Cristian Luput Director |
BUY
Open market or private purchase
|
Direct |
20,000
+4.55%
|
$20,000
$1.08 P/Share
|
|
Nov 25
2025
|
Cristian Luput Director |
BUY
Open market or private purchase
|
Direct |
10,000
+2.44%
|
$0
$0.98 P/Share
|
|
Nov 25
2025
|
Vlad Vitoc Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,500
+1.25%
|
$0
$0.97 P/Share
|
|
Nov 25
2025
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
15,000
+1.1%
|
$0
$0.98 P/Share
|
|
Nov 24
2025
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.74%
|
$0
$0.99 P/Share
|
|
Nov 24
2025
|
Vlad Vitoc Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+1.2%
|
$0
$0.99 P/Share
|
|
Nov 21
2025
|
Vlad Vitoc Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,800
+0.22%
|
$0
$0.92 P/Share
|
|
Oct 01
2025
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
19,230
+1.43%
|
$19,230
$1.3 P/Share
|
|
Jun 03
2025
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
33,333
+2.49%
|
$33,333
$1.5 P/Share
|
|
May 08
2025
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
66,666
+4.98%
|
$66,666
$1.5 P/Share
|
|
May 08
2025
|
Ramiro Guerrero Director |
BUY
Open market or private purchase
|
Direct |
20,000
+3.29%
|
$20,000
$1.5 P/Share
|
|
Mar 03
2025
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
25,000
+2.03%
|
$25,000
$1.5 P/Share
|
Last 12 Months Summary
Buy / Acquisition
697K
Shares
From
6
Insiders
| Open market or private purchase | 697K shares |
|---|
Sell / Disposition
0
Shares
From
0
Insiders